Mirna Therapeutics, Inc. MIRN
No live quote for MIRN yet.
Valuation
P/E 0.0×
FY 2024 5y median 0.0× FY 2025
P/S 0.0×
FY 2024 5y median 0.0× FY 2025
P/B 0.0×
FY 2024 5y median 0.0× FY 2025
P/FCF 0.0×
FY 2024 5y median 0.0× FY 2025
EV/EBITDA 3.7×
FY 2024 5y median 2.2× FY 2025
EV/Sales 0.0×
FY 2024 5y median -1179× FY 2025
FCF Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2024 5y median -255937.5% FY 2025
Net Margin 0.0%
FY 2024 5y median -145993.8% FY 2025
ROE -8.5%
FY 2024 5y median -95.8% FY 2025
ROIC -33.8%
FY 2024 5y median -177.5% FY 2025
ROA -6.5%
FY 2024 5y median -62.2% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2024 FY 2025
Operating Income 90.2%
FY 2024 FY 2025
EPS (diluted) 95.8%
FY 2024 FY 2025
Free Cash Flow 86.2%
FY 2024 FY 2025
Financial Health
Current Ratio 4.3×
FY 2024 5y median 3.5× FY 2025
Quick Ratio 4.3×
FY 2024 5y median 3.5× FY 2025
Debt / Equity 0.0×
FY 2024 5y median 0.0× FY 2025
Net Debt / EBITDA 3.7×
FY 2024 5y median 2.2× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31